2-(2-{5-[5-(azepan-1-ylmethyl)-2-thienyl]-1,2,4-oxadiazol-3-yl}ethyl)-1H-isoindole-1,3(2H)-dione | 201545-86-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: 2-(2-{5-[5-(azepan-1-ylmethyl)-2-thienyl]-1,2,4-oxadiazol-3-yl}ethyl)-1H-isoindole-1,3(2H)-dione
• 英文别名: 2-[2-[5-[5-(azepan-1-ylmethyl)thiophen-2-yl]-1,2,4-oxadiazol-3-yl]ethyl]isoindole-1,3-dione
• CAS: 201545-86-0
• 化学式: C₂₃H₂₄N₄O₃S
• 分子量: 436.5
• InChiKey: QUKKMGJVXHURCY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  31
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  108
• 氢给体数：
  0
• 氢受体数：
  7

文献信息

• NOVEL THIOPHENE DERIVATIVES AND DRUG COMPOSITIONS CONTAINING THE SAME
  申请人：YAMANOUCHI PHARMACEUTICAL CO., LTD.

  公开号：EP0921123A1

  公开（公告）日：1999-06-09

  A thiophene derivative represented by the following general formula (I) or a pharmaceutically acceptable salt thereof (each symbol in the above formula means as follows, R1:formula -A1-X1-R3, R2:formula -A2-X2-R4 or does not exist, B ring:1) 4- to 10-membered nitrogen-containing cycloalkyl ring, or 2) 5- or 6-membered nitrogen-containing unsaturated heterocycle, Ar ring:an aryl ring which may have a substituent, or a 5- or 6-membered aromatic heterocycle or an 8- to 10-membered aromatic bicyclic heterocycle, which contains 1 to 4 of one or more types of hetero atoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, A1, A2 and A3:the same or different from one another, and each represents a bond or a lower alkylene group, X1 and X2:the same or different from each other, and each represents a bond or a formula -O-, -S-, -NR5-, R5, R6, R7, R8, R9, R10, R11, R12 and R13:the same or different from one another, and each represents a hydrogen atom or a lower alkyl group, and R3 and R4:the same or different from each other, and each represents a hydrogen atom, a cyclic imido group which may have a substituent and may be condensed with a benzene ring, or a lower alkyl group, a cycloalkyl group, an aryl group or an aralkyl group, which may respectively have a substituent, with the proviso that, when Ar ring is thiazole ring, either one of A1 and A2 is a lower alkylene group, and when Ar ring is a benzene ring, a case in which R1 and R2 is methyl group or a halogen group and the other is a hydrogen atom is excluded).

  由以下通式（I）代表的噻吩衍生物或其药学上可接受的盐 (上式中各符号的含义如下、 R1：式-A1-X1-R3、 R2：式-A2-X2-R4 或不存在、 B 环：1）4 至 10 元含氮环烷基环、 或 2) 5 或 6 元含氮不饱和杂环、 Ar 环：芳基环，可带有取代基，或 5 或 6 元芳香杂环，或 8 至 10 元芳香双环杂环，其中含有 1 至 4 个从氮原子、氧原子和硫原子组成的组中选出的一种或多种杂原子、 A1、A2 和 A3：彼此相同或不同，各自代表一个键或一个低级亚烷基、 X1和X2:彼此相同或不同，各自代表键或式-O-、-S-、-NR5-、 R5、R6、R7、R8、R9、R10、R11、R12 和 R13：彼此相同或不同，各自代表氢原子或低级烷基，以及 R3 和 R4：相同或互不相同，各自代表氢原子、环状亚氨基（可带有取代基并可与苯环缩合）或低级烷基、环烷基、芳基或芳烷基（可分别带有取代基）、 但 Ar 环为噻唑环时，A1 和 A2 中的一个为低级亚烷基；Ar 环为苯环时，不包括 R1 和 R2 中的一个为甲基或卤素基，另一个为氢原子的情况）。
• US6090804A
  申请人：——

  公开号：US6090804A

  公开（公告）日：2000-07-18